Is Novartis AG NVS stock outperforming the market Q4 2025 EPS Misses Estimates Is Brixmor BRX stock appealing for longterm investors Q4 2025 Earnings Beat Estimates What idiosyncratic risk Exodus Movement EXOD Investor Concern 20260427